Vanlauwe Johan, Almqvist Frederik, Bellemans Johan, Huskin Jean-Pierre, Verdonk René, Victor Jan
University Hospital Leuven, Belgium.
Acta Orthop Belg. 2007 Apr;73(2):145-58.
An increasing number of patients with cartilage defects of the knee are being treated with autologous chondrocyte implantation (ACI). To date, no clear guidelines exist for the use and indications of this technique. The BVOT and SOBCOT have established a working group to review the clinical results and the cost-effectiveness of the various treatment modalities and particularly of ACI. This group has formulated recommendations and presents a treatment algorithm based on an in-depth review of recent European and American literature, on peer-reviewed opinions of leading investigators in the field and on a comparative analysis of the clinical results and health-economic aspects of current cartilage repair techniques.
越来越多的膝关节软骨缺损患者正在接受自体软骨细胞移植(ACI)治疗。迄今为止,对于该技术的使用和适应症尚无明确的指导方针。比利时骨与创伤外科学会(BVOT)和法国骨与创伤外科学会(SOBCOT)成立了一个工作组,以评估各种治疗方式,尤其是ACI的临床疗效和成本效益。该工作组在深入回顾近期欧美文献、该领域主要研究者的同行评审意见以及对当前软骨修复技术的临床疗效和卫生经济方面进行比较分析的基础上,制定了建议并提出了一种治疗方案。